ProNoxis AB
556773-2341ActiveDeveloping small molecule drugs targeting NOX2 activation for inflammation treatment.
Oversikt
- 0
- Ansatte
- 150–199t SEK
- Omsetning
- 2008
- Grunnlagt
Nøkkelbeslutningstakere
Peter Olofsson
CEO
Beskrivelse
ProNoxis is a specialized biotechnology company focused on the preclinical exploration of novel small-molecule therapeutics. Its core mission is developing oral drugs to treat chronic inflammatory, autoimmune, and infectious diseases. The company targets a unique mechanism by developing agonists tha...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556773234101
Beslutningstakere
1 kontakter i FunnelfeedrPeter Olofsson
CEO
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrRedoxis AB
19 ansatteSwedish CRO specializing in preclinical autoimmune and inflammatory disease models.
Inicure AB
Developing novel small molecules to combat resistant bacterial infections effectively.
Active Biotech AB (publ)
1–4 ansatteDeveloping novel treatments for cancer and inflammatory eye diseases.
VACARA AB
1–4 ansatteSwedish biotech developing RA diagnostics, vaccines, and therapeutics.
Novakand Pharma AB
Developing novel small-molecule drugs for inflammation and cancer.
Utforsk mer
Spørsmål om ProNoxis AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo